New Frontiers, Landmark Trials, and Evolving Treatment Paradigms for MS-A Year 2010 and Beyond Best Practice Update for the Neurology and MS Specialist
Bruce A. Cree, MD, PhD, MCR

The Emergence of Immunosuppressive Agents for MS: Safety, Efficacy, and Cautionary Notes-Patient Monitoring , Risks for Infection, and Mechanisms of Action
Mark J. Tullman, MD

The Long Haul: Optimizing Long-Term Functional Status and Financial Outcomes in RRMS with Immunomodulation Therapy: What Do The Trials Teach US?
Howard L. Zwibel, MD

The Foundation Role of Neuroimaging in Multiple Sclerosis-A Year 2010 State-of-the-Art Update
Daniel Pelletier, MD

Interactive Question and Answer Session
Faculty Panel